RxDoctor Payments Data

Josephine Redmond, PA

Physician Assistant · North Charleston, SCNPI 1245563725

Payments from drug & device makers

$553in general payments, 2019–2025

Across 26 payments — averaging $21.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insulet Corporation$107
  • AbbVie$91
  • AstraZeneca$58
  • GSK$45
  • Exact Sciences$42
  • Novartis$40
  • plus $169 from 7 others

What the payments were for

  • Food & beverage$553100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$553 in reported general payments places this provider in the 55th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$24,291
Medicare patients
99
Services billed
512

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide54$93,250
JanuviaSitagliptin Phosphate40$50,330
EliquisApixaban46$44,594
EntrestoSacubitril/Valsartan27$34,536
TrulicityDulaglutide24$33,432
FarxigaDapagliflozin Propanediol24$29,683
JardianceEmpagliflozin23$27,728
MounjaroTirzepatide14$16,905
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$16,545
LinzessLinaclotide15$15,902
Repatha SureclickEvolocumab11$15,896
Tresiba Flextouch U-100Insulin Degludec13$6,708
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$2,682
Albuterol Sulfate HfaAlbuterol Sulfate74$2,409
Rosuvastatin Calcium123$1,476

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$22$93,25054 claims
Lilly USA, LLCTrulicity, Mounjaro$34$50,33738 claims
AstraZenecaFarxiga, Breztri Aerosphere$58$46,22942 claims
PfizerEliquis$15$44,59446 claims
NovartisEntresto$40$34,53627 claims
Boehringer IngelheimJardiance$32$27,72823 claims
AbbVieLinzess$91$15,90215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in North Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →